Joinpoint analysis found an increasing trend in the use of IT among all patients combined from 2004 to 2021 (AAPC = 11.21, 95% CI: 9.67–13.93) as well as 2013–2021 (AAPC = 21.92, 95% CI: 19.63–26.86).
← all excerpts
Disparities in the Receipt of Immunotherapy for Patients With Head and Neck Mucosal Melanoma.
1
—
—